Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes
作者： Ralph S. Freedman , Chris D. Platsoucas
DOI: 10.1007/978-1-4613-1247-5_8
关键词: Ovarian carcinoma 、 Cancer 、 Carcinoma 、 Stromal cell 、 Medicine 、 Tumor-infiltrating lymphocytes 、 Ovary 、 Primary peritoneal carcinoma 、 Pathology 、 Metastasis
摘要: Cancer of the ovary is responsible for highest proportion mortality in patients with gynecologic malignancies. The overall survival these at 5 years 39% [1]. Epithelial ovarian carcinoma (EOC) represents 90% histologies and thus most frequent histologic group. Primary peritoneal carcinoma, also called extraovarian mullerian has same pattern tumor spread sensitivity to chemotherapy as EOC, although ovaries are not primarily involved pathologic process. Other malignancies that originate from include those germ cell stromal origin. These considered separately have a different clinical presentation response treatment.
springer.com
sci-hub.st 参考文章(110)
W.S. Peart, T.M. Andrews, J.I.S. Robertson, CARCINOID SYNDROME The Lancet. ,vol. 277, pp. 577- 578 ,(1961) , 10.1016/S0140-6736(61)92247-4
Rosenberg Sa, Immunotherapy of patients with advanced cancer using interleukin-2 alone or in combination with lymphokine activated killer cells. Important advances in oncology. pp. 217- 257 ,(1988)
Timothy L. Darrow, Hilliard F. Seigler, Nancy J. Crowley, Craig L. Slingluff, Generation of Human Autologous Melanoma-specific Cytotoxic T-Cells Using HLA-A2-matched Allogeneic Melanomas Cancer Research. ,vol. 50, pp. 492- 498 ,(1990)
S Rashed, R S Freedman, C D Platsoucas, C G Ioannides, C L Edwards, J T Wharton, Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites. Cancer Research. ,vol. 51, pp. 4257- 4265 ,(1991)
R B Herberman, T L Whiteside, D S Heo, A Kanbour, Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors. Journal of Immunology. ,vol. 140, pp. 4042- 4049 ,(1988)
N McCartney-Francis, S M Wahl, L M Wahl, A B Roberts, S Dougherty, G Hall, J A Schmidt, D A Hunt, H L Wong, L Ellingsworth, Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. Journal of Immunology. ,vol. 140, pp. 3026- 3032 ,(1988)
Carlos Cordon-Cardo, Lea Eisenbach, Marija Drobnjak, Michael Feldman, Carlos Moreno, Zvi Fuks, Expression of HLA-A,B,C Antigens on Primary and Metastatic Tumor Cell Populations of Human Carcinomas Cancer Research. ,vol. 51, pp. 6372- 6380 ,(1991)
D M Neville, J W Marsh, A flexible peptide spacer increases the efficacy of holoricin anti-T cell immunotoxins. Journal of Immunology. ,vol. 140, pp. 3674- 3678 ,(1988)
D J Schwartzentruber, S L Topalian, S A Rosenberg, M Mancini, Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation. Journal of Immunology. ,vol. 146, pp. 3674- 3681 ,(1991)
T J Eberlein, G E Peoples, P S Goedegebuure, M P Davey, D D Schoof, T cell receptor Vβ2 and Vβ6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer Journal of Immunology. ,vol. 151, pp. 5472- 5480 ,(1993)